The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
Abstract
Background.: Carbapenem-resistant Klebsiella pneumoniae is an emerging healthcare-associated pathogen. Objective.: To describe the epidemiology of and clinical outcomes associated with carbapenem-resistant K. pneumoniae infection and to identify risk factors associated with mortality among patients with this type of infection. Setting.: Mount Sinai Hospital, a 1,171-bed tertiary care teaching hospital in New York City. Design.: Two matched case-control studies. Methods.: In the first matched case-control study, case patients with carbapenem-resistant K. pneumoniae infection were compared with control patients with carbapenem-susceptible K. pneumoniae infection. In the second case-control study, patients who survived carbapenem-resistant K. pneumoniae infection were compared with those who did not survive, to identify risk factors associated with mortality among patients with carbapenem-resistant K. pneumoniae infection. Results.: There were 99 case patients and 99 control patients identified. Carbapenem-resistant K. pneumoniae infection was independently associated with recent organ or stem-cell transplantation (P = .008), receipt of mechanical ventilation (P = .04), longer length of stay before infection (P = .01), and exposure to cephalosporins (P = .02) and carbapenems (P < .001). Case patients were more likely than control patients to die during hospitalization (48% vs 20%; P < .001) and to die from infection (38% vs 12%; P < .001). Removal of the focus of infection (ie, debridement) was independently associated with patient survival (P = .002). The timely administration of antibiotics with in vitro activity against carbapenem-resistant K. pneumoniae was not associated with patient survival. Conclusions.: Carbapenem-resistant K. pneumoniae infection is associated with numerous healthcare-related risk factors and with high mortality. The mortality rate associated with carbapenem-resistant K. pneumoniae infection and the limited antimicrobial options for treatment of carbapenem-resistant K. pneumoniae infection highlight the need for improved detection of carbapenem-resistant K. pneumoniae infection, identification of effective preventive measures, and development of novel agents with reliable clinical efficacy against carbapenem-resistant K. pneumoniae.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
System, A. R. F. T. N. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.001 · Cited by 2,342
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Hospital Epidemiology and Infection Control
Mayhall, C. G. (2011) · Cited by 1,179
Engemann, J. J., Carmeli, Y., Cosgrove, S. E., Fowler, V. G., Bronstein, M. Z., Trivette, S. L., Briggs, J. P., Sexton, D. J., & Kaye, K. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367653 · Cited by 934
Cosgrove, S. E., Qi, Y., Kaye, K. S., Harbarth, S., Karchmer, A. W., & Carmeli, Y. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502522 · Cited by 856
Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/319757 · Cited by 747
Surveillance nosokomialer Infektionen
Gastmeier (2004) · Therapeutische Umschau · doi:10.1024/0040-5930.61.3.204 · Cited by 509
Schwaber, M. J., Klarfeld-Lidji, S., Navon-Venezia, S., Schwartz, D., Leavitt, A., & Carmeli, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01020-07 · Cited by 483
Bradford, P. A., Urban, C., Mariano, N., Projan, S. J., Rahal, J. J., & Bush, K. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.563 · Cited by 450
Surveillance of nosocomial infections
Rasley, D. A. (1989) · Critical Care Nursing Quarterly · doi:10.1097/00002727-198903000-00009 · Cited by 403
Bratu, S., Tolaney, P., Karumudi, U., Quale, J., Mooty, M., Nichani, S., & Landman, D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki175 · Cited by 307
Harris, A. D., Karchmer, T. B., Carmeli, Y., & Samore, M. H. (2001) · Clinical Infectious Diseases · doi:10.1086/319600 · Cited by 262
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study
Falagas, M. E., Rafailidis, P. I., Kofteridis, D. P., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm356 · Cited by 253
Bratu, S., Mooty, M., Nichani, S., Landman, D., Gullans, C., Pettinato, B., Karumudi, U., Tolaney, P., & Quale, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.3018-3020.2005 · Cited by 246
Reed, S. D., Friedman, J. Y., Engemann, J. J., Griffiths, R. I., Anstrom, K. J., Kaye, K. S., Stryjewski, M. E., Szczech, L. A., Reller, L. B., Corey, G. R., et al. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502523 · Cited by 200
Carbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing
Tenover, F. C., Kalsi, R. K., Williams, P. P., Carey, R. B., Stocker, S., Lonsway, D., Rasheed, J. K., Biddle, J. W., McGowan, J. E., & Hanna, B. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1208.060291 · Cited by 199
Landman, D., Bratu, S., Kochar, S., Panwar, M., Trehan, M., Doymaz, M., & Quale, J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm129 · Cited by 192
Deshpande, L. M., Jones, R. N., Fritsche, T. R., & Sader, H. S. (2006) · Microbial Drug Resistance · doi:10.1089/mdr.2006.12.223 · Cited by 169
Lee, S. Y., Kotapati, S., Kuti, J. L., Nightingale, C. H., & Nicolau, D. P. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/507962 · Cited by 143
Emergence of a carbapenem-resistant Kiebsiella pneumoniae
MacKenzie, F., Forbes, K., Dorai-John, T., Amyes, S., & Gould, I. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62567-6 · Cited by 101
Kwak, Y. G., Choi, S., Choo, E. J., Chung, J.-W., Jeong, J., Kim, N. J., Woo, J., Ryu, J., & Kim, Y. S. (2005) · Microbial Drug Resistance · doi:10.1089/mdr.2005.11.165 · Cited by 98
Strongyloides hyperinfection syndrome after intestinal transplantation
Patel, G., Arvelakis, A., Sauter, B. V., Gondolesi, G. E., Caplivski, D., & Huprikar, S. S. (2007) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2007.00256.x · Cited by 74
Self-citationChow, J. W., & Shlaes, D. M. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/28.4.499 · Cited by 74
Daly, M. W., Riddle, D. J., Ledeboer, N. A., Dunne, W. M., & Ritchie, D. J. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.7.1052 · Cited by 72
Cited by
Global Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
Gupta, N., Limbago, B. M., Patel, J. B., & Kallen, A. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir202 · Cited by 1,033
Snitkin, E. S., Zelazny, A. M., Thomas, P. J., Stock, F., Program, N. C. S., Henderson, D. K., Palmore, T. N., & Segre, J. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004129 · Cited by 863
Carbapenem Resistance: A Review
Codjoe, F., & Donkor, E. (2017) · Medical Sciences · doi:10.3390/medsci6010001 · Cited by 746
Averbuch, D., Orasch, C., Cordonnier, C., Livermore, D. M., Mikulska, M., Viscoli, C., Gyssens, I. C., Kern, W. V., Klyasova, G., Marchetti, O., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.091025 · Cited by 632
Metadata
- Authors
- Patel, G., Huprikar, S., Factor, S. H., Jenkins, S. G., & Calfee, D. P.
- Venue
- Infection Control & Hospital Epidemiology
- Publisher
- Cambridge University Press (CUP)
- Published
- 2008-12
- Volume
- 29
- Issue
- 12
- Pages
- 1099-1106
- ISSN
- 0899-823X (ISSN-L)
- 1559-6834
- OpenAlex
- W2196782563
- Cited by
- 836
- References
- 25
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.